Abstract
Arbutamine, a synthetic catecholamine, coupled with a closed-loop, computerized delivery system was evaluated in conjunction with technetium-99m sestamibi scintigraphy and echocardiography for the detection of coronary artery disease. Concordance between the imaging methods was 68%, with a similar sensitivity for coronary disease using echocardiography (78%) and technetium-99m sestamibi (76%), although more arbutamine-induced ischemia was noted with perfusion imaging.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adrenergic beta-Agonists*
-
Catecholamines*
-
Coronary Disease / diagnostic imaging*
-
Coronary Vessels / diagnostic imaging
-
Diagnosis, Differential
-
Echocardiography / methods*
-
Humans
-
Predictive Value of Tests
-
Radionuclide Imaging
-
Radiopharmaceuticals*
-
Sensitivity and Specificity
-
Technetium Tc 99m Sestamibi*
Substances
-
Adrenergic beta-Agonists
-
Catecholamines
-
Radiopharmaceuticals
-
Technetium Tc 99m Sestamibi
-
arbutamine